Global Bacteriophage Therapy Market Insights, Forecast to 2028

SKU ID :QYR-20466236 | Published Date: 10-Mar-2022 | No. of pages: 126
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bacteriophage Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oral 1.2.3 Topical 1.2.4 Parenteral 1.3 Market by Application 1.3.1 Global Bacteriophage Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Organ Transplantation 1.3.3 Bacterial Infections 1.3.4 Alcoholic Hepatitis 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Bacteriophage Therapy Market Perspective (2017-2028) 2.2 Bacteriophage Therapy Growth Trends by Region 2.2.1 Bacteriophage Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Bacteriophage Therapy Historic Market Size by Region (2017-2022) 2.2.3 Bacteriophage Therapy Forecasted Market Size by Region (2023-2028) 2.3 Bacteriophage Therapy Market Dynamics 2.3.1 Bacteriophage Therapy Industry Trends 2.3.2 Bacteriophage Therapy Market Drivers 2.3.3 Bacteriophage Therapy Market Challenges 2.3.4 Bacteriophage Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Bacteriophage Therapy Players by Revenue 3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2017-2022) 3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Bacteriophage Therapy Revenue 3.4 Global Bacteriophage Therapy Market Concentration Ratio 3.4.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2021 3.5 Bacteriophage Therapy Key Players Head office and Area Served 3.6 Key Players Bacteriophage Therapy Product Solution and Service 3.7 Date of Enter into Bacteriophage Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Bacteriophage Therapy Breakdown Data by Type 4.1 Global Bacteriophage Therapy Historic Market Size by Type (2017-2022) 4.2 Global Bacteriophage Therapy Forecasted Market Size by Type (2023-2028) 5 Bacteriophage Therapy Breakdown Data by Application 5.1 Global Bacteriophage Therapy Historic Market Size by Application (2017-2022) 5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Bacteriophage Therapy Market Size (2017-2028) 6.2 North America Bacteriophage Therapy Market Size by Type 6.2.1 North America Bacteriophage Therapy Market Size by Type (2017-2022) 6.2.2 North America Bacteriophage Therapy Market Size by Type (2023-2028) 6.2.3 North America Bacteriophage Therapy Market Share by Type (2017-2028) 6.3 North America Bacteriophage Therapy Market Size by Application 6.3.1 North America Bacteriophage Therapy Market Size by Application (2017-2022) 6.3.2 North America Bacteriophage Therapy Market Size by Application (2023-2028) 6.3.3 North America Bacteriophage Therapy Market Share by Application (2017-2028) 6.4 North America Bacteriophage Therapy Market Size by Country 6.4.1 North America Bacteriophage Therapy Market Size by Country (2017-2022) 6.4.2 North America Bacteriophage Therapy Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Bacteriophage Therapy Market Size (2017-2028) 7.2 Europe Bacteriophage Therapy Market Size by Type 7.2.1 Europe Bacteriophage Therapy Market Size by Type (2017-2022) 7.2.2 Europe Bacteriophage Therapy Market Size by Type (2023-2028) 7.2.3 Europe Bacteriophage Therapy Market Share by Type (2017-2028) 7.3 Europe Bacteriophage Therapy Market Size by Application 7.3.1 Europe Bacteriophage Therapy Market Size by Application (2017-2022) 7.3.2 Europe Bacteriophage Therapy Market Size by Application (2023-2028) 7.3.3 Europe Bacteriophage Therapy Market Share by Application (2017-2028) 7.4 Europe Bacteriophage Therapy Market Size by Country 7.4.1 Europe Bacteriophage Therapy Market Size by Country (2017-2022) 7.4.2 Europe Bacteriophage Therapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Bacteriophage Therapy Market Size (2017-2028) 8.2 Asia-Pacific Bacteriophage Therapy Market Size by Type 8.2.1 Asia-Pacific Bacteriophage Therapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Bacteriophage Therapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Bacteriophage Therapy Market Share by Type (2017-2028) 8.3 Asia-Pacific Bacteriophage Therapy Market Size by Application 8.3.1 Asia-Pacific Bacteriophage Therapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Bacteriophage Therapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Bacteriophage Therapy Market Share by Application (2017-2028) 8.4 Asia-Pacific Bacteriophage Therapy Market Size by Region 8.4.1 Asia-Pacific Bacteriophage Therapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Bacteriophage Therapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Bacteriophage Therapy Market Size (2017-2028) 9.2 Latin America Bacteriophage Therapy Market Size by Type 9.2.1 Latin America Bacteriophage Therapy Market Size by Type (2017-2022) 9.2.2 Latin America Bacteriophage Therapy Market Size by Type (2023-2028) 9.2.3 Latin America Bacteriophage Therapy Market Share by Type (2017-2028) 9.3 Latin America Bacteriophage Therapy Market Size by Application 9.3.1 Latin America Bacteriophage Therapy Market Size by Application (2017-2022) 9.3.2 Latin America Bacteriophage Therapy Market Size by Application (2023-2028) 9.3.3 Latin America Bacteriophage Therapy Market Share by Application (2017-2028) 9.4 Latin America Bacteriophage Therapy Market Size by Country 9.4.1 Latin America Bacteriophage Therapy Market Size by Country (2017-2022) 9.4.2 Latin America Bacteriophage Therapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Bacteriophage Therapy Market Size (2017-2028) 10.2 Middle East & Africa Bacteriophage Therapy Market Size by Type 10.2.1 Middle East & Africa Bacteriophage Therapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Bacteriophage Therapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Bacteriophage Therapy Market Share by Type (2017-2028) 10.3 Middle East & Africa Bacteriophage Therapy Market Size by Application 10.3.1 Middle East & Africa Bacteriophage Therapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Bacteriophage Therapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Bacteriophage Therapy Market Share by Application (2017-2028) 10.4 Middle East & Africa Bacteriophage Therapy Market Size by Country 10.4.1 Middle East & Africa Bacteriophage Therapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Bacteriophage Therapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Armata Pharmaceuticals, Inc. 11.1.1 Armata Pharmaceuticals, Inc. Company Details 11.1.2 Armata Pharmaceuticals, Inc. Business Overview 11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction 11.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.1.5 Armata Pharmaceuticals, Inc. Recent Developments 11.2 Eliava Biopreparations Ltd. 11.2.1 Eliava Biopreparations Ltd. Company Details 11.2.2 Eliava Biopreparations Ltd. Business Overview 11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction 11.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2017-2022) 11.2.5 Eliava Biopreparations Ltd. Recent Developments 11.3 Pherecydes Pharma 11.3.1 Pherecydes Pharma Company Details 11.3.2 Pherecydes Pharma Business Overview 11.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction 11.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2017-2022) 11.3.5 Pherecydes Pharma Recent Developments 11.4 Intralytix, Inc. 11.4.1 Intralytix, Inc. Company Details 11.4.2 Intralytix, Inc. Business Overview 11.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction 11.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.4.5 Intralytix, Inc. Recent Developments 11.5 Phagelux Inc. 11.5.1 Phagelux Inc. Company Details 11.5.2 Phagelux Inc. Business Overview 11.5.3 Phagelux Inc. Bacteriophage Therapy Introduction 11.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.5.5 Phagelux Inc. Recent Developments 11.6 Nextbiotics 11.6.1 Nextbiotics Company Details 11.6.2 Nextbiotics Business Overview 11.6.3 Nextbiotics Bacteriophage Therapy Introduction 11.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2017-2022) 11.6.5 Nextbiotics Recent Developments 11.7 InnoPhage, Ltd 11.7.1 InnoPhage, Ltd Company Details 11.7.2 InnoPhage, Ltd Business Overview 11.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction 11.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2017-2022) 11.7.5 InnoPhage, Ltd Recent Developments 11.8 Locus Biosciences, Inc. 11.8.1 Locus Biosciences, Inc. Company Details 11.8.2 Locus Biosciences, Inc. Business Overview 11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction 11.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.8.5 Locus Biosciences, Inc. Recent Developments 11.9 TechnoPhage 11.9.1 TechnoPhage Company Details 11.9.2 TechnoPhage Business Overview 11.9.3 TechnoPhage Bacteriophage Therapy Introduction 11.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2017-2022) 11.9.5 TechnoPhage Recent Developments 11.10 Eligo Bioscience SA 11.10.1 Eligo Bioscience SA Company Details 11.10.2 Eligo Bioscience SA Business Overview 11.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction 11.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2017-2022) 11.10.5 Eligo Bioscience SA Recent Developments 11.11 Phagomed Biopharma GmbH. 11.11.1 Phagomed Biopharma GmbH. Company Details 11.11.2 Phagomed Biopharma GmbH. Business Overview 11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction 11.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2017-2022) 11.11.5 Phagomed Biopharma GmbH. Recent Developments 11.12 PhagePro, Inc. 11.12.1 PhagePro, Inc. Company Details 11.12.2 PhagePro, Inc. Business Overview 11.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction 11.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.12.5 PhagePro, Inc. Recent Developments 11.13 Adaptive Phage Therapeutics, Inc. 11.13.1 Adaptive Phage Therapeutics, Inc. Company Details 11.13.2 Adaptive Phage Therapeutics, Inc. Business Overview 11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction 11.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments 11.14 EnBiotix, Inc. 11.14.1 EnBiotix, Inc. Company Details 11.14.2 EnBiotix, Inc. Business Overview 11.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction 11.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.14.5 EnBiotix, Inc. Recent Developments 11.15 Intodeworld, Inc. 11.15.1 Intodeworld, Inc. Company Details 11.15.2 Intodeworld, Inc. Business Overview 11.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction 11.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) 11.15.5 Intodeworld, Inc. Recent Developments 11.16 BiomX Ltd. 11.16.1 BiomX Ltd. Company Details 11.16.2 BiomX Ltd. Business Overview 11.16.3 BiomX Ltd. Bacteriophage Therapy Introduction 11.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2017-2022) 11.16.5 BiomX Ltd. Recent Developments 11.17 Phi Therapeutics 11.17.1 Phi Therapeutics Company Details 11.17.2 Phi Therapeutics Business Overview 11.17.3 Phi Therapeutics Bacteriophage Therapy Introduction 11.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2017-2022) 11.17.5 Phi Therapeutics Recent Developments 11.18 Fixed-phage Ltd. 11.18.1 Fixed-phage Ltd. Company Details 11.18.2 Fixed-phage Ltd. Business Overview 11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction 11.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2017-2022) 11.18.5 Fixed-phage Ltd. Recent Developments 11.19 Micreos BV 11.19.1 Micreos BV Company Details 11.19.2 Micreos BV Business Overview 11.19.3 Micreos BV Bacteriophage Therapy Introduction 11.19.4 Micreos BV Revenue in Bacteriophage Therapy Business (2017-2022) 11.19.5 Micreos BV Recent Developments 11.20 ContraFect Corporation 11.20.1 ContraFect Corporation Company Details 11.20.2 ContraFect Corporation Business Overview 11.20.3 ContraFect Corporation Bacteriophage Therapy Introduction 11.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2017-2022) 11.20.5 ContraFect Corporation Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Bacteriophage Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Table 3. Key Players of Topical Table 4. Key Players of Parenteral Table 5. Global Bacteriophage Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Bacteriophage Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Bacteriophage Therapy Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Bacteriophage Therapy Market Share by Region (2017-2022) Table 9. Global Bacteriophage Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Bacteriophage Therapy Market Share by Region (2023-2028) Table 11. Bacteriophage Therapy Market Trends Table 12. Bacteriophage Therapy Market Drivers Table 13. Bacteriophage Therapy Market Challenges Table 14. Bacteriophage Therapy Market Restraints Table 15. Global Bacteriophage Therapy Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Bacteriophage Therapy Revenue Share by Players (2017-2022) Table 17. Global Top Bacteriophage Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2021) Table 18. Ranking of Global Top Bacteriophage Therapy Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Bacteriophage Therapy Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Bacteriophage Therapy Product Solution and Service Table 22. Date of Enter into Bacteriophage Therapy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Bacteriophage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Bacteriophage Therapy Revenue Market Share by Type (2017-2022) Table 26. Global Bacteriophage Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Bacteriophage Therapy Revenue Market Share by Type (2023-2028) Table 28. Global Bacteriophage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Bacteriophage Therapy Revenue Share by Application (2017-2022) Table 30. Global Bacteriophage Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Bacteriophage Therapy Revenue Share by Application (2023-2028) Table 32. North America Bacteriophage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Bacteriophage Therapy Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Bacteriophage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Bacteriophage Therapy Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Bacteriophage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Bacteriophage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Bacteriophage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Bacteriophage Therapy Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Bacteriophage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Bacteriophage Therapy Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Bacteriophage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Bacteriophage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Bacteriophage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Bacteriophage Therapy Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Bacteriophage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Bacteriophage Therapy Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Bacteriophage Therapy Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Bacteriophage Therapy Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Bacteriophage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Bacteriophage Therapy Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Bacteriophage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Bacteriophage Therapy Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Bacteriophage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Bacteriophage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Bacteriophage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Bacteriophage Therapy Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Bacteriophage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Bacteriophage Therapy Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Bacteriophage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Bacteriophage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 62. Armata Pharmaceuticals, Inc. Company Details Table 63. Armata Pharmaceuticals, Inc. Business Overview Table 64. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Table 65. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 66. Armata Pharmaceuticals, Inc. Recent Developments Table 67. Eliava Biopreparations Ltd. Company Details Table 68. Eliava Biopreparations Ltd. Business Overview Table 69. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Table 70. Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 71. Eliava Biopreparations Ltd. Recent Developments Table 72. Pherecydes Pharma Company Details Table 73. Pherecydes Pharma Business Overview Table 74. Pherecydes Pharma Bacteriophage Therapy Product Table 75. Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 76. Pherecydes Pharma Recent Developments Table 77. Intralytix, Inc. Company Details Table 78. Intralytix, Inc. Business Overview Table 79. Intralytix, Inc. Bacteriophage Therapy Product Table 80. Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 81. Intralytix, Inc. Recent Developments Table 82. Phagelux Inc. Company Details Table 83. Phagelux Inc. Business Overview Table 84. Phagelux Inc. Bacteriophage Therapy Product Table 85. Phagelux Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 86. Phagelux Inc. Recent Developments Table 87. Nextbiotics Company Details Table 88. Nextbiotics Business Overview Table 89. Nextbiotics Bacteriophage Therapy Product Table 90. Nextbiotics Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 91. Nextbiotics Recent Developments Table 92. InnoPhage, Ltd Company Details Table 93. InnoPhage, Ltd Business Overview Table 94. InnoPhage, Ltd Bacteriophage Therapy Product Table 95. InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 96. InnoPhage, Ltd Recent Developments Table 97. Locus Biosciences, Inc. Company Details Table 98. Locus Biosciences, Inc. Business Overview Table 99. Locus Biosciences, Inc. Bacteriophage Therapy Product Table 100. Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 101. Locus Biosciences, Inc. Recent Developments Table 102. TechnoPhage Company Details Table 103. TechnoPhage Business Overview Table 104. TechnoPhage Bacteriophage Therapy Product Table 105. TechnoPhage Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 106. TechnoPhage Recent Developments Table 107. Eligo Bioscience SA Company Details Table 108. Eligo Bioscience SA Business Overview Table 109. Eligo Bioscience SA Bacteriophage Therapy Product Table 110. Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 111. Eligo Bioscience SA Recent Developments Table 112. Phagomed Biopharma GmbH. Company Details Table 113. Phagomed Biopharma GmbH. Business Overview Table 114. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Table 115. Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 116. Phagomed Biopharma GmbH. Recent Developments Table 117. PhagePro, Inc. Company Details Table 118. PhagePro, Inc. Business Overview Table 119. PhagePro, Inc. Bacteriophage Therapy Product Table 120. PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 121. PhagePro, Inc. Recent Developments Table 122. Adaptive Phage Therapeutics, Inc. Company Details Table 123. Adaptive Phage Therapeutics, Inc. Business Overview Table 124. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Table 125. Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 126. Adaptive Phage Therapeutics, Inc. Recent Developments Table 127. EnBiotix, Inc. Company Details Table 128. EnBiotix, Inc. Business Overview Table 129. EnBiotix, Inc. Bacteriophage Therapy Product Table 130. EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 131. EnBiotix, Inc. Recent Developments Table 132. Intodeworld, Inc. Company Details Table 133. Intodeworld, Inc. Business Overview Table 134. Intodeworld, Inc. Bacteriophage Therapy Product Table 135. Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 136. Intodeworld, Inc. Recent Developments Table 137. BiomX Ltd. Company Details Table 138. BiomX Ltd. Business Overview Table 139. BiomX Ltd. Bacteriophage Therapy Product Table 140. BiomX Ltd. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 141. BiomX Ltd. Recent Developments Table 142. Phi Therapeutics Company Details Table 143. Phi Therapeutics Business Overview Table 144. Phi Therapeutics Bacteriophage Therapy Product Table 145. Phi Therapeutics Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 146. Phi Therapeutics Recent Developments Table 147. Fixed-phage Ltd. Company Details Table 148. Fixed-phage Ltd. Business Overview Table 149. Fixed-phage Ltd. Bacteriophage Therapy Product Table 150. Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 151. Fixed-phage Ltd. Recent Developments Table 152. Micreos BV Company Details Table 153. Micreos BV Business Overview Table 154. Micreos BV Bacteriophage Therapy Product Table 155. Micreos BV Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 156. Micreos BV Recent Developments Table 157. ContraFect Corporation Company Details Table 158. ContraFect Corporation Business Overview Table 159. ContraFect Corporation Bacteriophage Therapy Product Table 160. ContraFect Corporation Revenue in Bacteriophage Therapy Business (2017-2022) & (US$ Million) Table 161. ContraFect Corporation Recent Developments Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Global Bacteriophage Therapy Market Share by Type: 2021 VS 2028 Figure 2. Oral Features Figure 3. Topical Features Figure 4. Parenteral Features Figure 5. Global Bacteriophage Therapy Market Share by Application: 2021 VS 2028 Figure 6. Organ Transplantation Case Studies Figure 7. Bacterial Infections Case Studies Figure 8. Alcoholic Hepatitis Case Studies Figure 9. Other Case Studies Figure 10. Bacteriophage Therapy Report Years Considered Figure 11. Global Bacteriophage Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Bacteriophage Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Bacteriophage Therapy Market Share by Region: 2021 VS 2028 Figure 14. Global Bacteriophage Therapy Market Share by Players in 2021 Figure 15. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2021 Figure 17. North America Bacteriophage Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Bacteriophage Therapy Market Size Market Share by Type (2017-2028) Figure 19. North America Bacteriophage Therapy Market Size Market Share by Application (2017-2028) Figure 20. North America Bacteriophage Therapy Market Size Share by Country (2017-2028) Figure 21. United States Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Bacteriophage Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Bacteriophage Therapy Market Size Market Share by Type (2017-2028) Figure 25. Europe Bacteriophage Therapy Market Size Market Share by Application (2017-2028) Figure 26. Europe Bacteriophage Therapy Market Size Share by Country (2017-2028) Figure 27. Germany Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Bacteriophage Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Bacteriophage Therapy Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Bacteriophage Therapy Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Bacteriophage Therapy Market Size Share by Region (2017-2028) Figure 37. China Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Bacteriophage Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Bacteriophage Therapy Market Size Market Share by Type (2017-2028) Figure 45. Latin America Bacteriophage Therapy Market Size Market Share by Application (2017-2028) Figure 46. Latin America Bacteriophage Therapy Market Size Share by Country (2017-2028) Figure 47. Mexico Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Bacteriophage Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Bacteriophage Therapy Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Bacteriophage Therapy Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Bacteriophage Therapy Market Size Share by Country (2017-2028) Figure 53. Turkey Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Bacteriophage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 57. Eliava Biopreparations Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 58. Pherecydes Pharma Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 59. Intralytix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 60. Phagelux Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 61. Nextbiotics Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 62. InnoPhage, Ltd Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 63. Locus Biosciences, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 64. TechnoPhage Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 65. Eligo Bioscience SA Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 66. Phagomed Biopharma GmbH. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 67. PhagePro, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 68. Adaptive Phage Therapeutics, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 69. EnBiotix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 70. Intodeworld, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 71. BiomX Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 72. Phi Therapeutics Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 73. Fixed-phage Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 74. Micreos BV Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 75. ContraFect Corporation Revenue Growth Rate in Bacteriophage Therapy Business (2017-2022) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed
Armata Pharmaceuticals, Inc. Eliava Biopreparations Ltd. Pherecydes Pharma Intralytix, Inc. Phagelux Inc. Nextbiotics InnoPhage, Ltd Locus Biosciences, Inc. TechnoPhage Eligo Bioscience SA Phagomed Biopharma GmbH. PhagePro, Inc. Adaptive Phage Therapeutics, Inc. EnBiotix, Inc. Intodeworld, Inc. BiomX Ltd. Phi Therapeutics Fixed-phage Ltd. Micreos BV ContraFect Corporation
  • PRICE
  • $4900
    $9800
    $7350

Our Clients